Medicaid drug costs are much lower than Medicare Part D costs, report finds
Aug 17, 2011
Medicaid’s net unit drug costs are much lower than costs under Medicare Part D, which is attributed to higher Medicaid rebates for brand name medications, according to a new report.
Clinical briefs for Friday, Nov. 6
By
Alicia Lasek
Nov 06, 2020
Rates of breast cancer gene detection decrease in senior women … Regeneron hopes U.S. soon will authorize coronavirus antibody drug … Medicaid expansion linked to lower mortality in three major cancer...
Regular exercise may delay decline in those at risk of Alzheimer’s
By
Alicia Lasek
Aug 09, 2019
Moderate exercise appears to help preserve memory and curb brain changes in people at risk of Alzheimer’s, new studies show.
Big wound treatment in a small package
By
John O'Connor
Mar 01, 2011
An inexpensive nanometer-sized drug that can treat foot ulcers and other chronic wounds has been developed by a group of scientists from the Hebrew University of Jerusalem, Harvard Medical School and others...
World’s oldest person turns 115 at Indiana nursing home
Apr 22, 2008
The woman believed to be the oldest person in the world celebrated her 115th birthday on Sunday at Heritage House Convalescent Center in Shelbyville, IN.
Clinical briefs for Wednesday, April 14
By
Alicia Lasek
Apr 14, 2021
NIH updates monoclonal antibody COVID treatment protocols … Surveyed community pharmacists say vaccine supply is bigger problem than patient reluctance … B.1.1.7 variant more transmissible but does...
Quitting smoking reverses lung cell damage: study
By
Alicia Lasek
Jan 30, 2020
Quitting appears to reawaken healthy cells, triggering airways to regrow a new lining – even in lifelong smokers.
Introspection has 2 payoffs
By
Mary Gustafson
Sep 01, 2012
A meditation technique reduces loneliness and chronic inflammation disorders in seniors, new research shows.
Medicare Advantage pay to jump as enrollment grows
By
James M. Berklan
May 08, 2018
Medicare Advantage plans will receive a 3.4% uptick in federal payments in 2019. That’s nearly 90% more than the 1.84% increase proposed in February. Notice of the bigger raise came in the Centers...
FDA OKs new insulin biosimilar for type 2 diabetes
By
Alicia Lasek
Jul 30, 2021
Semglee is a safe and more cost-effective alternative to the drug Lantus (insulin glargine), the agency announced Wednesday. Semglee does not need a prescriber’s input to be substituted at the pharmacy.